FDA approves first inhalable version of insulin

Exubera to offer diabetics an alternative to daily injections.

First inhalable version the insulin, which gives million Erwachsendiabetiker an alternative to some the injections, which carry it now. The food and drug administration have the insulin of Pfizer Inc. indicated, in order on the market like Exubera to be introduced the first new kind is of supplying the insulin since the discovery of the hormone in the twenties.

Pfizer developed together the drug and the distributor with thérapeutique of Sanofi Aventis and of Nektar. It would have to be at the disposal of the patients by the so-called center of the yearly, Pfizer. The employment of the inhalierten insulin of the current fast action will not replace the necessity to inject the hormone after FDA occasionally. And the Diabetiker must sting further their fingers, in order to examine sets of the sugar in the blood.

The American diabetes association believed that nearly 21 million persons in the United States have the diabetes. Approximately 5 million injections of insulin of the need. The analysts said to receive that the inhalierte insulin could go later well to a salesman from $1 milliard un années for Pfizer, who accepted recently to pay at Sanofi Aventis $1,3 billion in order full world-wide rights at the drug for type 1 and 2 Erwachsendiabetiker.

It is said to Dr. Steven Galson director of the center our hope that the availability of the inhalierten insulin patient will offer more options, around the order to improve their blood sugar “of FDA for the evaluation and the drug research. The commission approved of European Exubera for the use in the adults Thursday